title: Novel approach for bladder cancer treatment using sulfoquinovosylacylpropanediol as a radiosensitizer.
authors.affiliation: Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
authors.forename: Takafumi
authors.initials: T
authors.lastname: Yagisawa
authors.affiliation: Department of Urology, Tokyo Women's Medical University, Tokyo, Japan. okumi@kc.twmu.ac.jp.
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Okumi
authors.affiliation: Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
authors.forename: Kazuya
authors.initials: K
authors.lastname: Omoto
authors.affiliation: Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
authors.forename: Yugo
authors.initials: Y
authors.lastname: Sawada
authors.affiliation: Department of Anatomy and Developmental Biology, Tokyo Women's Medical University, Tokyo, Japan.
authors.forename: Shunichi
authors.initials: S
authors.lastname: Morikawa
authors.affiliation: Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
authors.forename: Kazunari
authors.initials: K
authors.lastname: Tanabe
mesh_terms: D000818:Animals; D001808:Blood Vessels / Q000187:drug effects / Q000528:radiation effects; D045744:Cell Line, Tumor; D059248:Chemoradiotherapy / Q000379:methods; D006017:Glycolipids / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D011836:Radiation Tolerance / Q000187:drug effects; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000098:blood supply / Q000628:therapy*; D023041:Xenograft Model Antitumor Assays
chemical_list: D006017:Glycolipids; D011838:Radiation-Sensitizing Agents; C000605760:sulfoquinovosylacylpropanediol